Arcadia Biosciences (RKDA) Tops Q3 EPS by 19c

Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.10), $0.19 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $2.51 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• Whirlpool to close Mexico plant, expects $165M restructuring cost
• Culp, Inc. (CULP) Misses Q4 EPS by 12c